Study of the correlations between serum iron and Hepcidin with some biochemical variables in hyperlipidemia of elderly males and females in Salah Al Deen Province
Article Sidebar
Main Article Content
Abstract
The present research was designed to investigate the role of the relationship between Iron and hepcidin hormon with some biochemical variables in patients with hyperlipidemia in both males and females elderly in Salah al-Din governorate. The study included 40 individuals distributed into two groups. The first group was the control group, which included 20 human males and females and the second group included 20 patients (10 males and 10 females) whose ages ranged between (60-79) years. Blood was collected to estimate the hepcidine hormone, iron, cholesterol, triglycerides, high-density lipoproteins, low-density lipoproteins, and very low-density lipoproteins. The results showed a significant increase in (P≥ 0.05) in the concentration of iron and hepcidin hormone, cholesterol, triglycerides, low-density lipoproteins and very low-density lipoproteins while showed a significant decrease in (P≥ 0.05) in the concentration high-density lipoproteins in patients Males and females hyperlipidemia compared to the control group. The results also indicated a direct correlation relationship between iron and hepcidine hormone and studied variables cholesterol, triglycerides, low-density lipoproteins and very low-density lipoproteins in patients compared to the control group. It is concluded through the results that iron and the hepcidin hormon may have an important role in the development of cardiovascular diseases in hypertensive patients in elderly both males and females.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Galesloot, T. E.; Geurts - Moespot, A. J.; den Heijer, M.; Sweep, F. C.; Fleming, R. E.; Kiemeney, L. A., and Swinkels, D. W. (2013). Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study. J of medical genetics, 50(9), 593-598.
[2] Roy, C.N; Mak, H.H; Akpan, I; Losyev, G; Zurakowski, D; Andrews, N.C.(2007). Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood.109:4038–4044. [3] Yayar, Ö.; Eser, B. and Kılıç, H. (2018). Relation between high serum hepcidin - 25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients. Anatolian journal of cardiology, 19 (2), 117.
[4] Valenti, L.; Dongiovanni, P.; Motta, B. M.; Swinkels, D. W.; Bonara, P.; Rametta, R. and Fargion, S. (2011). Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arteriosclerosis, thrombosis, and vascular biology, 31(3), 683-690.
[5] Hicham, B.; Claudia, N. M.; Abdelouahed, K. (2012). Health benefits of high-density lipoprotein in preventing cardiovascular disease. J of Clinical lipidology , 6, (6) : 524-533 .
[6] Alvarez, E.; Cairra˜o, E.; Morgado, M.; Morais, C and Verde I.( 2010). Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition. Advances in Pharmacological Sciences.
[7] David, G. G.; Asha, J.; Dolores, S. (2012). Greenspan᾽s Basic and clinical Endocrinology . Yale J Biol. Med. 85(4) : 559-570.
[8] Nemeth, E.; and Ganz, T. (2006). Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr., 26, 323-342.
[9] Ronald Hoffman, E.J.B.; Leslie, E. Silberstein; Helen, E. Heslop; Jeffrey, I. Weitz and John Anastasi, (2013). Hematology: Basic Principles and Practice. 6 ed., Philadelphia, PA Elsevier Health Sciences
[10] Díaz, V.; Peinado, A. B.; Barba‐Moreno, L.; Altamura, S.; Butragueño, J.; González‐Gross, M. and Gassmann, (2015). Elevated hepcidin serum level in response to inflammatory and iron signals in exercising athletes is independent of moderate supplementation with vitamin C and E. Physiological reports, 3(8), e12475
[11] Gassmann, M. and Muckenthaler, M. U. (2015). Adaptation of iron requirement to hypoxic conditions at high altitude. J of Applied Physiology, 119(12), 1432-1440.
[12] Kong, WN; NiuQM; GeL; Zheng N; Yan SF; Chen WB; Chang Yz; Zhao. SE(2014).Sex differences in iron status and hepcidin expression in rats. 160(2):258-67 [13] Kuragano, T.; Itoh, K.; Shimonaka, Y.; Kida, A., Furuta, M.; Kitamura, R. and Nonoguchi, H. (2011). Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrology Dialysis Transplantation, 26(8), 2663-2667.
[14] Engberink, M.F; Povel, C.M; Durga J; Swinkels ,D.W; de Kort ,W.L, Schouten, E.G; Verhoef, P; Geleijnse, J.M.(2010). Hemochromatosis (HFE) genotype and atherosclerosis: increased susceptibility to iron-induced vascular damage in C282Y carriers Atherosclerosis.211:520 –525.
[15] Pigeon, C.; Ilyin, G.; Courselaud, B.; Leroyer, P.; Turlin, B.; Brissot, P. and Loréal, O. (2001). A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J of biological chemistry, 276(11), 7811-7819.
[16] Nemeth, E.; Valore, E. V.; Territo, M.; Schiller, G.; Lichtenstein, A.; and Ganz, T. (2003). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101(7), 2461-2463 [17] Pechlaner, R.; Kiechl, S.; Mayr, M.; Santer, P.; Weger, S.; Haschka, D.,and Weiss, G. (2016). Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clinical Chemistry and Laboratory Medicine (CCLM), 54(1), 151-161.
[18] Zoller ,H; KOCH RO; Theurl I; Obrist P; Pietrangelo A; MontosiG; Haile DJ; Vogel W and Weiss G;(2001) Expression of the duodenal iron transporters divalent- metal transporter Iand ferroportin I in iron dificiency and iron overload. Gastroenterology ; 120: 1412- 1419.
[19] Girelli, D.; Nemeth, E.; and Swinkels, D. W. (2016). Hepcidin in the diagnosis of iron disorders. Blood, 127(23), 2809-2813. [20] Edlow, J. A.; Panagos, P. D.; Godwin, S. A.; Thomas, T. L., and Decker, W. W. (2009). Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. J of Emergency Nursing, 35(3), e43-e71.
[21] Ridgway, N. and McLeod, R. (2016). Biochemistry of lipids, lipoproteins and membranes. Elsevier. .330, 331, 361, 437, 438, 524, 525.